Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

Pincas Bitterman, MD

Pincas Bitterman, MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Pathology-Anatomic
Board Certification:
  • Pathology-Anatomic
Faculty Rank: Professor
Medical or Graduate Education: Biomedical Sciences Institute (Autonomous University of Ciudad Juarez), Mexico
Residency: Hospital of Saint Raphael - Anatomic and Clinical Pathology
  Georgetown University Hospital - Anatomic and Clinical Pathology
Fellowship: Georgetown University Hospital/Johns Hopkins Hospital - Anatomic and Clinical Pathology
  Georgetown University Hospital - Anatomic and Clinical Pathology
Clinical Expertise:
  • Fine-needle aspiration biopsy
Research Interests:
  • Uterine carcinosarcoma
  • Low grade malignancies of the ovary
  • Molecular diagnostics in breast and gynecological tumors
Languages Spoken:
  • Hebrew
  • Spanish
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Interleukin 16 expression changes in association with ovarian malignant transformation.
    Yellapa A, Bitterman P, Sharma S, Guirguis AS, Bahr JM, Basu S, Abramowicz JS, Barua A
    Am. J. Obstet. Gynecol.
    2014 Mar
    210(3):272.e1-10.
  2. Enhancement of ovarian tumor detection with avß3 integrin-targeted ultrasound molecular imaging agent in laying hens: a preclinical model of spontaneous ovarian cancer.
    Barua A, Yellapa A, Bahr JM, Machado SA, Bitterman P, Basu S, Sharma S, Abramowicz JS
    Int. J. Gynecol. Cancer
    2014 Jan
    24(1):19-28.
  3. Intraoperative imprint cytology of ovarian transitional cell (Brenner) tumors: A retrospective study.
    Singh RI, Rosen L, Reddy VB, Bitterman P, Stemm MH, Gattuso P
    Diagn. Cytopathol.
    2014 Feb 18
  4. Immunohistochemical characterization of squamous differentiation and morular metaplasia in uterine endometrioid adenocarcinoma.
    Blanco LZ Jr, Heagley DE, Lee JC, Gown AM, Gattuso P, Rotmensch J, Guirguis A, Dewdney S, Bitterman P.
    Int J Gynecol Pathol. 2013
    2013 May
    32(3):283-92. doi: 10.1097/PGP.0b013e31826129e1.
  5. Androgen Receptor Expression in Vascular Neoplasms of the Breast.
    Jain R, Bitterman P, Lamzabi I, Reddy VB, Gattuso P.
    Appl Immunohistochem Mol Morphol. 2013
    2013 Mar 25. [Epub ahead of print]
  6. Use of cervical mucus to screen for gynecological malignancies: a pilot study.
    Lamzabi I, Buckingham L, Gebrekiristos M, Jain R, Gattuso P, Reddy V, Guirguis A, Dewdney S, Rotmensch J, Bitterman P.
    Mod Pathol. 2013
    2013 Jun 14. doi: 10.1038/modpathol.2013.92. [Epub ahead of print]
  7. Immunophenotype of Myxopapillary Ependymomas.
    Lamzabi I, Arvanitis LD, Reddy VB, Bitterman P, Gattuso P.
    Appl Immunohistochem Mol Morphol. 2013
    2013 Feb 28. [Epub ahead of print]
  8. Dietary supplementation of Ashwagandha (Withania somnifera, Dunal) enhances NK cell function in ovarian tumors in the laying hen model of spontaneous ovarian cancer.
    Barua A, Bradaric MJ, Bitterman P, Abramowicz JS, Sharma S, Basu S, Lopez H, Bahr JM
    Am. J. Reprod. Immunol.
    2013 Dec
    70(6):538-50.
  9. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer.
    Yellapa A, Bahr JM, Bitterman P, Abramowicz JS, Edassery SL, Penumatsa K, Basu S, Rotmensch J, Barua A.
    Int J Gynecol Cancer. 2012
    2012 Feb
    22(2):199-207. doi: 10.1097/IGC.0b013e318236a27b.
  10. Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer.
    Barua A, Yellapa A, Bahr JM, Abramowicz JS, Edassery SL, Basu S, Rotmensch J, Bitterman P.
    Transl Oncol. 2012
    2012 Aug
    5(4):260-8. Epub 2012 Aug 1.
  11. Expression of Leukocyte Inhibitory Immunoglobulin-like Transcript 3 Receptors by Ovarian Tumors in Laying Hen Model of Spontaneous Ovarian Cancer.
    Khan MF, Bahr JM, Yellapa A, Bitterman P, Abramowicz JS, Edassery SL, Basu S, Rotmensch J, Barua A.
    Transl Oncol. 2012
    2012 Apr
    5(2):85-91. Epub 2012 Apr 1.
  12. Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model.
    Barua A, Bitterman P, Bahr JM, Basu S, Sheiner E, Bradaric MJ, Hales DB, Luborsky JL, Abramowicz JS.
    J Ultrasound Med. 2011
    2011 Mar
    30(3):333-45.
  13. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
    Patsavas K, Woessner J, Gielda B, Rotmensch J, Yordan E, Bitterman P, Guirguis A.
    Gynecol Oncol. 2011
    2011 Jun 1
    121(3):581-5. doi: 10.1016/j.ygyno.2010.11.048. Epub 2011 Mar 25.
  14. Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder.
    Gould VE, Schmitt M, Vinokurova S, Reddy VB, Bitterman P, Alonso A, Gattuso P.
    Cancer Lett. 2010
    2010 Jun 28
    292(2):171-5. doi: 10.1016/j.canlet.2009.11.022. Epub 2009 Dec 29.
  15. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer.
    Barua A, Bitterman P, Bahr JM, Bradaric MJ, Hales DB, Luborsky JL, Abramowicz JS.
    J Ultrasound Med. 2010
    2010 Feb
    29(2):173-82.
  16. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.
    Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Edassery SL, Rotmensch J, Luborsky JL.
    Int J Gynecol Cancer. 2009
    2009 May
    19(4):531-9. doi: 10.1111/IGC.0b013e3181a41613.
  17. Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.
    Barua A, Edassery SL, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, Bradaric MJ, Luborsky JL.
    Int J Gynecol Cancer. 2009
    2009 May
    19(4):500-7. doi: 10.1111/IGC.0b013e3181a39db1.
  18. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
    Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, Hales DB, Luborsky JL.
    Gynecol Oncol. 2008
    2008 Apr
    109(1):115-21. doi: 10.1016/j.ygyno.2007.12.030. Epub 2008 Feb 13.

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612